Replies to post #33196 on Medizone Intl. (fka MZEIQ)

[BenK]

OK, I see your point.

I would guess that the examples you mention about drugs in the pipeline refers to established companies, who sink tens of millions of dollars into a potential drug, and also have an advertising budget of many millions.

Our problem is the Catch-22 of a tiny budget for publicity, no credibility built up (or more accurately, a credibility deficit), and the great difficulty in getting media exposure until we've become established.

The time will come that we'll get bona fide media exposure in our own right, but that too will have to develop in its own pace.

JMO.

[never-say-die]

The reason Medizone only attracts a few thousand dollars a day in trading can be summed up in one word.

Credibility.

Do you really think the upcoming quarterly report is going to show the year end sale of 40 or more machines as Marshall projected?

Year after year, the company has suffered from the publication of false and misleading information.

Even when genuine good news does come along it is pretty much ignored by serious investors given the source.

For the foreseeable future investment in Medizone is going to be limited to small time speculators raiding the cookie jar.

The stupid publication of false and misleading information has fortunately stopped. However, it has been replaced by an equally stupid policy of silence.

Investor relations at Medizone can only be described as the deaf, dumb and blind leading the deaf, dumb and blind.